HAILEY TEAT: Open Payments
NPI 1417527755 · SHREVEPORT, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$449 in 22 payments from 13 companies in 2025. Trend: 2023 $488 · 2024 $517 · 2025 $449
Food & beverage: $449
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 3 | $72 |
| Esperion Therapeutics, Inc. | 4 | $57 |
| ABIOMED | 2 | $49 |
| E.R. Squibb & Sons, L.L.C. | 2 | $48 |
| Alnylam Pharmaceuticals Inc. | 2 | $40 |
| Kestra Medical Technology Services, Inc. | 1 | $37 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $33 |
| Recor Medical Inc | 1 | $20 |
| Becton, Dickinson and Company | 1 | $20 |
| Amgen Inc. | 1 | $18 |
Products named: VERQUVO, NEXLETOL, CAMZYOS, AMVUTTRA, Assure WCD, Kerendia, Paradise Ultrasound Renal Denervation System, RotarexS 6 F x 135 cm.
Industry payments across LA — which companies pay providers there.
